Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology

• Filippo de Marinis,
• Ilaria Attili,
• Cesare Gridelli,
• Fabiana Cecere,
• Carlo Curcio,
• Francesco Facciolo,
• Lorenzo Spaggiari,
• Lorenzo Spaggiari

Affiliations

Filippo de Marinis

European Institute of Oncology, IRCCS, Division of Thoracic Oncology, Milan, Italy

Ilaria Attili

European Institute of Oncology, IRCCS, Division of Thoracic Oncology, Milan, Italy

Cesare Gridelli

’S.G. Moscati’ Hospital, Division of Medical Oncology, Avellino, Italy

Fabiana Cecere

Regina Elena National Cancer Institute, IRCCS, Oncology 1, Rome, Italy

Carlo Curcio

Department of Thoracic Surgery, Monaldi Hospital, Naples, Italy

Francesco Facciolo

Thoracic Surgery Unit, Regina Elena National Cancer Institute, IRCCS, Rome, Italy

Lorenzo Spaggiari

European Institute of Oncology, IRCCS, Division of Thoracic Surgery, Milan, Italy

Lorenzo Spaggiari

Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy